LUMVYTA

What this means for you

This application is over — abandoned 09 Jun 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

97462842

Mark type

Design + words

Filed

16 Jun 2022

Abandoned

09 Jun 2023

Attorney of record

Connie L. Ellerbach

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations; pharmaceutical preparations for human use; pharmaceutical preparation for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of oncological diseases; pharmaceutical preparations and substances for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; targeted medical preparations for use in the field of cancer prevention and treatment; medical and veterinary preparations for the delivery of compounds to the body for the treatment and prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
• Class 044 — Medical, beauty and agricultural services: Medical information services; healthcare services; research, development, and evaluation of pharmaceutical preparations for the prevention and treatment of cancer; laboratory analysis and research of drugs and pharmaceutical products; research and development services in the fields of oncology, immunotherapy, chemotherapy, and combination therapies for the treatment of cancer and tumors; providing medical research information in the fields of oncology, immunotherapy, chemotherapy and combination therapies; scientific advisory services, namely, providing scientific information, advice, and consultancy in the field of cancer treatment; healthcare services, namely, providing cancer treatment information to physicians, health care professionals, and patients; design, development, research, and testing of drugs and pharmaceuticals for the treatment and/or prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medical information services, namely, providing information regarding viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Owner

• Day One Biopharmaceuticals, Inc., Brisbane, CA, US

Prosecution history

• 26 Jun 2023 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
• 24 Jun 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
• 24 Jun 2023 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
• 08 Mar 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 08 Mar 2023 — NON-FINAL ACTION E-MAILED
• 08 Mar 2023 — NON-FINAL ACTION WRITTEN
• 07 Mar 2023 — ASSIGNED TO EXAMINER
• 14 Sept 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
• 14 Sept 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
• 14 Sept 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
• 02 Jul 2022 — NOTICE OF DESIGN SEARCH CODE E-MAILED
• 01 Jul 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 20 Jun 2022 — NEW APPLICATION ENTERED